会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Refractory period tracking and arrhythmia detection
    • 难治期跟踪和心律失常检测
    • US07184832B2
    • 2007-02-27
    • US10680528
    • 2003-10-07
    • D. Curtis DenoRuth N. KlepferWilliam J. HavelDavid M. SchneiderVincent E. Splett
    • D. Curtis DenoRuth N. KlepferWilliam J. HavelDavid M. SchneiderVincent E. Splett
    • A61N1/365
    • A61N1/365A61N1/3622
    • Techniques and apparatus for estimating the temporal refractory period of a heart, for adjusting a parameter for delivery of extra-systolic stimulation (ESS) therapy and for detecting an arrhythmia during delivery of ESS therapy In some aspects, probe pulses are periodically delivered to estimate the location of the end boundary of the refractory period, and accordingly estimate its length. In some embodiments, the parameter is adjusted based on estimated length of the refractory period. For example, an extra-systolic interval (ESI) for delivery of ESS is adjusted to be a fixed interval longer than estimated lengths of the refractory period. In other aspects, the parameter is adjusted based on a measured delay (or latency) between delivery of an ESS pulse and detection of an evoked response resulting from the pulse. Also, delays between delivery of an ESS pulse and detection of a subsequent depolarization are monitored to detect an arrhythmia.
    • 用于估计心脏的时间不应期的技术和装置,用于调整用于递送收缩期刺激(ESS)治疗的参数和用于在递送ESS治疗期间检测心律失常的一些方面,定期递送探针脉冲以估​​计 不应期结束边界的位置,并据此估计其长度。 在一些实施例中,基于估计的不应期的长度来调整参数。 例如,用于递送ESS的收缩期间期(ESI)被调整为比不应期的估计长度更长的固定间隔。 在其他方面,基于在递送ESS脉冲和从脉冲产生的诱发响应的检测之间的测量延迟(或等待时间)来调整参数。 此外,监测递送ESS脉冲和检测随后的去极化之间的延迟以检测心律失常。
    • 6. 发明授权
    • Shunt-current reduction housing for an implantable therapy system
    • 用于植入式治疗系统的分流电流还原壳体
    • US08473057B2
    • 2013-06-25
    • US12609901
    • 2009-10-30
    • William T. DonofrioWilliam J. HavelChris C. ChristiansenPaul G. Krause
    • William T. DonofrioWilliam J. HavelChris C. ChristiansenPaul G. Krause
    • A61N1/375
    • A61N1/375A61N1/08A61N1/36114A61N1/37A61N1/3718A61N1/37211A61N1/37288A61N1/3925A61N1/3962
    • Techniques for minimizing interference between first and second medical devices of a therapy system may include providing an outer housing for at least one of the medical devices that comprises an electrically insulative layer formed over at least the electrically conductive portions (e.g., an electrically conductive layer) of the housing, or providing an electrically insulative pouch around an electrically conductive housing of at least the first medical device. The electrically insulative layer or electrically insulative pouch may reduce or even eliminate shunt-current that flows into the medical device via the housing. The shunt-current may be generated by the delivery of electrical stimulation by the second medical device. In some examples, the techniques may also include shunt-current mitigation circuitry that helps minimize or even eliminate shunt-current that feeds into the first medical device via one or more electrodes electrically connected to the first medical device.
    • 用于最小化治疗系统的第一和第二医疗装置之间的干扰的技术可以包括提供用于至少一个医疗装置的外壳,其包括在至少导电部分(例如,导电层)上形成的电绝缘层, 或者提供围绕至少第一医疗装置的导电外壳的电绝缘袋。 电绝缘层或电绝缘袋可以减少甚至消除通过外壳流入医疗装置的分流电流。 分流电流可以通过第二医疗装置的电刺激的传递来产生。 在一些示例中,所述技术还可以包括分流电流缓解电路,其帮助最小化或甚至消除通过电连接到第一医疗设备的一个或多个电极馈入第一医疗设备的分流电流。
    • 8. 发明授权
    • Endoluminal prosthesis and delivery device
    • 腔内假体和输送装置
    • US09308107B2
    • 2016-04-12
    • US13595636
    • 2012-08-27
    • William J. Havel
    • William J. Havel
    • A61F2/06A61F2/954A61F2/966
    • A61F2/954A61F2/07A61F2/966A61F2002/065A61F2002/067
    • A system for treating a body vessel may include a delivery device and a prosthesis retained on the delivery device. The prosthesis may include a main body and first and second legs each extending from the main body. The main body may include a lumen, and the first leg may include a lumen in fluid communication with the lumen of the main body. The second leg may include a tubular graft body and a stent attached to the graft body. The prosthesis may have a predeployment configuration in which the graft body of the second leg is inverted into and positioned within the lumen of the first leg, and the stent is positioned outside of the inverted graft body. The prosthesis may have a deployed configuration in which the second leg extends outward from the main body, and the stent is positioned within a lumen of the graft body.
    • 用于治疗身体血管的系统可以包括输送装置和保留在输送装置上的假体。 假体可以包括主体以及从主体延伸的第一和第二腿。 主体可以包括腔,并且第一腿可以包括与主体的内腔流体连通的内腔。 第二腿部可以包括管状移植体和附接到移植物体的支架。 假体可以具有预部署构造,其中第二腿的移植物体被倒置并位于第一腿的内腔内,并且支架位于倒置的移植物体的外侧。 假体可以具有展开构造,其中第二腿从主体向外延伸,并且支架位于移植物主体的内腔内。
    • 10. 发明授权
    • Method and apparatus for post-shock evaluation using tissue oxygenation measurements
    • 使用组织氧合测量进行休克后评估的方法和装置
    • US08630708B2
    • 2014-01-14
    • US12845818
    • 2010-07-29
    • Jonathan L. KuhnCan CinbisDavid A. AndersonWilliam J. Havel
    • Jonathan L. KuhnCan CinbisDavid A. AndersonWilliam J. Havel
    • A61N1/365
    • A61B5/14551A61B5/1459A61B5/6846A61B5/7285A61N1/36557A61N1/3925A61N1/3956
    • A method and device for delivering therapy that includes an electrode to sense cardiac signals and to deliver a therapy, a therapy delivery module coupled to the electrode to deliver a therapy via the electrode in response to the sensed cardiac signals, a sensor emitting light and detecting emitted light scattered by a tissue volume adjacent the sensor to generate a corresponding detected light intensity output signal, a control module coupled to the sensor to control light emission of the sensor in response to delivering the therapy; and a controller coupled to the therapy delivery module and the sensor, the controller configured to determine a tissue oxygenation measurement in response to the output signal, and determine whether the delivered therapy was successful in restoring cardiac hemodynamic function in response to the tissue oxygenation measurement.
    • 一种用于递送治疗的方法和装置,其包括用于感测心脏信号并递送治疗的电极,治疗递送模块,其耦合到所述电极,以响应于感测到的心脏信号经由所述电极递送治疗;发射光和检测的传感器 发射由邻近传感器的组织体积散射的光,以产生相应的检测到的光强度输出信号;控制模块,其耦合到所述传感器,以响应于递送所述治疗来控制所述传感器的光发射; 以及耦合到所述治疗递送模块和所述传感器的控制器,所述控制器被配置为响应于所述输出信号确定组织氧合测量,并且确定所递送的治疗是否成功响应于所述组织氧合测量来恢复心脏血液动力学功能。